Menu Search
Equities

Immunocore Holdings PLC

6YG:FRA

Immunocore Holdings PLC

Actions
  • Price (EUR)31.60
  • Today's Change-0.600 / -1.86%
  • Shares traded150.00
  • 1 Year change-31.90%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 20:55 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Immunocore Holdings PLC had net income fall 5.22% from a loss of 52.54m to a larger loss of 55.29m despite a 43.05% increase in revenues from 174.36m to 249.43m.
Gross margin99.41%
Net profit margin-18.99%
Operating margin-21.78%
Return on assets-6.75%
Return on equity-15.02%
Return on investment-8.35%
More ▼

Cash flow in USDView more

In 2023, Immunocore Holdings PLC increased its cash reserves by 9.98%, or 40.15m. Cash Flow from Financing totalled 34.35m or 13.77% of revenues. In addition the company generated 2.94m in cash from operations while cash used for investing totalled 5.43m.
Cash flow per share-0.9965
Price/Cash flow per share--
Book value per share7.18
Tangible book value per share7.18
More ▼

Balance sheet in USDView more

Immunocore Holdings PLC appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 442.63m. In fact, 0.26% of the value of Immunocore Holdings PLC shares can be attributed to this cash.
Current ratio5.17
Quick ratio5.15
Total debt/total equity1.22
Total debt/total capital0.5495
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.